1 Ophthalmic Solution Market Overview 1.1 Product Overview and Scope of Ophthalmic Solution 1.2 Ophthalmic Solution Segment by Type 1.2.1 Global Ophthalmic Solution Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Prescription Drugs 1.2.3 OTC Drugs 1.3 Ophthalmic Solution Segment by Application 1.3.1 Global Ophthalmic Solution Sales Comparison by Application: (2022-2028) 1.3.2 Inflammation/Infection 1.3.3 Relieve Fatigue 1.3.4 Others 1.4 Global Ophthalmic Solution Market Size Estimates and Forecasts 1.4.1 Global Ophthalmic Solution Revenue 2017-2028 1.4.2 Global Ophthalmic Solution Sales 2017-2028 1.4.3 Ophthalmic Solution Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ophthalmic Solution Market Competition by Manufacturers 2.1 Global Ophthalmic Solution Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ophthalmic Solution Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ophthalmic Solution Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ophthalmic Solution Manufacturing Sites, Area Served, Product Type 2.5 Ophthalmic Solution Market Competitive Situation and Trends 2.5.1 Ophthalmic Solution Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ophthalmic Solution Players Market Share by Revenue 2.5.3 Global Ophthalmic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ophthalmic Solution Retrospective Market Scenario by Region 3.1 Global Ophthalmic Solution Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ophthalmic Solution Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ophthalmic Solution Market Facts & Figures by Country 3.3.1 North America Ophthalmic Solution Sales by Country 3.3.2 North America Ophthalmic Solution Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ophthalmic Solution Market Facts & Figures by Country 3.4.1 Europe Ophthalmic Solution Sales by Country 3.4.2 Europe Ophthalmic Solution Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ophthalmic Solution Market Facts & Figures by Region 3.5.1 Asia Pacific Ophthalmic Solution Sales by Region 3.5.2 Asia Pacific Ophthalmic Solution Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ophthalmic Solution Market Facts & Figures by Country 3.6.1 Latin America Ophthalmic Solution Sales by Country 3.6.2 Latin America Ophthalmic Solution Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ophthalmic Solution Market Facts & Figures by Country 3.7.1 Middle East and Africa Ophthalmic Solution Sales by Country 3.7.2 Middle East and Africa Ophthalmic Solution Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Ophthalmic Solution Historic Market Analysis by Type 4.1 Global Ophthalmic Solution Sales Market Share by Type (2017-2022) 4.2 Global Ophthalmic Solution Revenue Market Share by Type (2017-2022) 4.3 Global Ophthalmic Solution Price by Type (2017-2022) 5 Global Ophthalmic Solution Historic Market Analysis by Application 5.1 Global Ophthalmic Solution Sales Market Share by Application (2017-2022) 5.2 Global Ophthalmic Solution Revenue Market Share by Application (2017-2022) 5.3 Global Ophthalmic Solution Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Senju Pharmaceutical 6.1.1 Senju Pharmaceutical Corporation Information 6.1.2 Senju Pharmaceutical Description and Business Overview 6.1.3 Senju Pharmaceutical Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Senju Pharmaceutical Ophthalmic Solution Product Portfolio 6.1.5 Senju Pharmaceutical Recent Developments/Updates 6.2 Allergan 6.2.1 Allergan Corporation Information 6.2.2 Allergan Description and Business Overview 6.2.3 Allergan Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Allergan Ophthalmic Solution Product Portfolio 6.2.5 Allergan Recent Developments/Updates 6.3 Novartis 6.3.1 Novartis Corporation Information 6.3.2 Novartis Description and Business Overview 6.3.3 Novartis Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Novartis Ophthalmic Solution Product Portfolio 6.3.5 Novartis Recent Developments/Updates 6.4 Pfizer 6.4.1 Pfizer Corporation Information 6.4.2 Pfizer Description and Business Overview 6.4.3 Pfizer Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Pfizer Ophthalmic Solution Product Portfolio 6.4.5 Pfizer Recent Developments/Updates 6.5 Merck 6.5.1 Merck Corporation Information 6.5.2 Merck Description and Business Overview 6.5.3 Merck Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Merck Ophthalmic Solution Product Portfolio 6.5.5 Merck Recent Developments/Updates 6.6 Genentech 6.6.1 Genentech Corporation Information 6.6.2 Genentech Description and Business Overview 6.6.3 Genentech Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Genentech Ophthalmic Solution Product Portfolio 6.6.5 Genentech Recent Developments/Updates 6.7 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description and Business Overview 6.6.3 Teva Ophthalmic Solution Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Teva Ophthalmic Solution Product Portfolio 6.7.5 Teva Recent Developments/Updates 7 Ophthalmic Solution Manufacturing Cost Analysis 7.1 Ophthalmic Solution Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ophthalmic Solution 7.4 Ophthalmic Solution Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ophthalmic Solution Distributors List 8.3 Ophthalmic Solution Customers 9 Ophthalmic Solution Market Dynamics 9.1 Ophthalmic Solution Industry Trends 9.2 Ophthalmic Solution Market Drivers 9.3 Ophthalmic Solution Market Challenges 9.4 Ophthalmic Solution Market Restraints 10 Global Market Forecast 10.1 Ophthalmic Solution Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ophthalmic Solution by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ophthalmic Solution by Type (2023-2028) 10.2 Ophthalmic Solution Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ophthalmic Solution by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ophthalmic Solution by Application (2023-2028) 10.3 Ophthalmic Solution Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ophthalmic Solution by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ophthalmic Solution by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ophthalmic Solution Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million) Table 2. Global Ophthalmic Solution Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million) Table 3. Global Ophthalmic Solution Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ophthalmic Solution Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ophthalmic Solution Sales (K Dose) of Key Manufacturers (2017-2022) Table 6. Global Ophthalmic Solution Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ophthalmic Solution Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ophthalmic Solution Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ophthalmic Solution Average Price (USD/Dose) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ophthalmic Solution Manufacturing Sites and Area Served Table 11. Manufacturers Ophthalmic Solution Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ophthalmic Solution by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmic Solution as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ophthalmic Solution Sales by Region (2017-2022) & (K Dose) Table 16. Global Ophthalmic Solution Sales Market Share by Region (2017-2022) Table 17. Global Ophthalmic Solution Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ophthalmic Solution Revenue Market Share by Region (2017-2022) Table 19. North America Ophthalmic Solution Sales by Country (2017-2022) & (K Dose) Table 20. North America Ophthalmic Solution Sales Market Share by Country (2017-2022) Table 21. North America Ophthalmic Solution Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ophthalmic Solution Revenue Market Share by Country (2017-2022) Table 23. Europe Ophthalmic Solution Sales by Country (2017-2022) & (K Dose) Table 24. Europe Ophthalmic Solution Sales Market Share by Country (2017-2022) Table 25. Europe Ophthalmic Solution Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ophthalmic Solution Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ophthalmic Solution Sales by Region (2017-2022) & (K Dose) Table 28. Asia Pacific Ophthalmic Solution Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ophthalmic Solution Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ophthalmic Solution Revenue Market Share by Region (2017-2022) Table 31. Latin America Ophthalmic Solution Sales by Country (2017-2022) & (K Dose) Table 32. Latin America Ophthalmic Solution Sales Market Share by Country (2017-2022) Table 33. Latin America Ophthalmic Solution Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ophthalmic Solution Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ophthalmic Solution Sales by Country (2017-2022) & (K Dose) Table 36. Middle East and Africa Ophthalmic Solution Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ophthalmic Solution Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ophthalmic Solution Revenue Market Share by Country (2017-2022) Table 39. Global Ophthalmic Solution Sales by Type (2017-2022) & (K Dose) Table 40. Global Ophthalmic Solution Sales Market Share by Type (2017-2022) Table 41. Global Ophthalmic Solution Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ophthalmic Solution Revenue Share by Type (2017-2022) Table 43. Global Ophthalmic Solution Price by Type (2017-2022) & (USD/Dose) Table 44. Global Ophthalmic Solution Sales (K Dose) by Application (2017-2022) Table 45. Global Ophthalmic Solution Sales Market Share by Application (2017-2022) Table 46. Global Ophthalmic Solution Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ophthalmic Solution Revenue Share by Application (2017-2022) Table 48. Global Ophthalmic Solution Price by Application (2017-2022) & (USD/Dose) Table 49. Senju Pharmaceutical Corporation Information Table 50. Senju Pharmaceutical Description and Business Overview Table 51. Senju Pharmaceutical Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 52. Senju Pharmaceutical Ophthalmic Solution Product Table 53. Senju Pharmaceutical Recent Developments/Updates Table 54. Allergan Corporation Information Table 55. Allergan Description and Business Overview Table 56. Allergan Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 57. Allergan Ophthalmic Solution Product Table 58. Allergan Recent Developments/Updates Table 59. Novartis Corporation Information Table 60. Novartis Description and Business Overview Table 61. Novartis Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 62. Novartis Ophthalmic Solution Product Table 63. Novartis Recent Developments/Updates Table 64. Pfizer Corporation Information Table 65. Pfizer Description and Business Overview Table 66. Pfizer Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 67. Pfizer Ophthalmic Solution Product Table 68. Pfizer Recent Developments/Updates Table 69. Merck Corporation Information Table 70. Merck Description and Business Overview Table 71. Merck Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 72. Merck Ophthalmic Solution Product Table 73. Merck Recent Developments/Updates Table 74. Genentech Corporation Information Table 75. Genentech Description and Business Overview Table 76. Genentech Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 77. Genentech Ophthalmic Solution Product Table 78. Genentech Recent Developments/Updates Table 79. Teva Corporation Information Table 80. Teva Description and Business Overview Table 81. Teva Ophthalmic Solution Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022) Table 82. Teva Ophthalmic Solution Product Table 83. Teva Recent Developments/Updates Table 84. Production Base and Market Concentration Rate of Raw Material Table 85. Key Suppliers of Raw Materials Table 86. Ophthalmic Solution Distributors List Table 87. Ophthalmic Solution Customers List Table 88. Ophthalmic Solution Market Trends Table 89. Ophthalmic Solution Market Drivers Table 90. Ophthalmic Solution Market Challenges Table 91. Ophthalmic Solution Market Restraints Table 92. Global Ophthalmic Solution Sales Forecast by Type (2023-2028) & (K Dose) Table 93. Global Ophthalmic Solution Sales Market Share Forecast by Type (2023-2028) Table 94. Global Ophthalmic Solution Revenue Forecast by Type (2023-2028) & (US$ Million) Table 95. Global Ophthalmic Solution Revenue Market Share Forecast by Type (2023-2028) Table 96. Global Ophthalmic Solution Sales Forecast by Application (2023-2028) & (K Dose) Table 97. Global Ophthalmic Solution Sales Market Share Forecast by Application (2023-2028) Table 98. Global Ophthalmic Solution Revenue Forecast by Application (2023-2028) & (US$ Million) Table 99. Global Ophthalmic Solution Revenue Market Share Forecast by Application (2023-2028) Table 100. Global Ophthalmic Solution Sales Forecast by Region (2023-2028) & (K Dose) Table 101. Global Ophthalmic Solution Sales Market Share Forecast by Region (2023-2028) Table 102. Global Ophthalmic Solution Revenue Forecast by Region (2023-2028) & (US$ Million) Table 103. Global Ophthalmic Solution Revenue Market Share Forecast by Region (2023-2028) Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ophthalmic Solution Figure 2. Global Ophthalmic Solution Market Share by Type in 2021 & 2028 Figure 3. Prescription Drugs Product Picture Figure 4. OTC Drugs Product Picture Figure 5. Global Ophthalmic Solution Market Share by Application in 2021 & 2028 Figure 6. Inflammation/Infection Figure 7. Relieve Fatigue Figure 8. Others Figure 9. Global Ophthalmic Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Ophthalmic Solution Market Size (2017-2028) & (US$ Million) Figure 11. Global Ophthalmic Solution Sales (2017-2028) & (K Dose) Figure 12. Ophthalmic Solution Sales Share by Manufacturers in 2021 Figure 13. Global Ophthalmic Solution Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Ophthalmic Solution Players: Market Share by Revenue in 2021 Figure 15. Ophthalmic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Ophthalmic Solution Sales Market Share by Region (2017-2022) Figure 17. Global Ophthalmic Solution Sales Market Share by Region in 2021 Figure 18. Global Ophthalmic Solution Revenue Market Share by Region (2017-2022) Figure 19. Global Ophthalmic Solution Revenue Market Share by Region in 2021 Figure 20. U.S. Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Taiwan Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Philippines Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Vietnam Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Turkey Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Saudi Arabia Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. UAE Ophthalmic Solution Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Sales Market Share of Ophthalmic Solution by Type (2017-2022) Figure 45. Manufacturing Cost Structure of Ophthalmic Solution Figure 46. Manufacturing Process Analysis of Ophthalmic Solution Figure 47. Ophthalmic Solution Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Senju Pharmaceutical Allergan Novartis Pfizer Merck Genentech Teva